NCT05754593Recruiting
Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared to a Control Group
Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis, Compared to a Control Group
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
The investigators want to evaluate ovarian reserve concerning patients with multiple sclerosis, compared to a control group of healthy women. This study will include women from 25 to 35 years old.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- First submitted
- 21 Feb 2023
- Start date
- 4 Dec 2023
- Primary completion date
- Dec 2027
- Lead sponsor
- University Hospital, Bordeaux
- Diseases
- Multiple sclerosis
- NCT number
- NCT05754593
What you commit to
- Study type: Interventional
- Planned participants: 160
- From 4 Dec 2023 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of ovarian surgery (cystectomy, annexectomy) ;
- Turner Syndrome ;
- History of chemotherapy or pelvic radiotherapy ;
Age
- patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent).
Other
- fragile X messenger ribonucleoprotein 1 (FMR1) premutation ;
- Endometriosis with a risk of ovarian reserve alteration ;
- Pregnant or breastfeeding women ;
Who the study is looking for
- Reproductive women between 25 and 35 years old ;
- MS Patient : Diagnosis of multiple sclerosis based on McDonald Criteria 2017;
- French-speaking, without comprehension disorders ;
- being affiliated to health insurance ;
- Willing to participate and to sign informed consent.
Age in the registry: 25 years to 35 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Bordeaux - service de neurologie Coordinator of this site? Confirm its status | Bordeaux | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.